Snowball logo
logo
GUD

Knight Therapeutics Inc

CA$10.32-CA$0.32Β  (3.01%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
243.5293.6328.2371.3450.1547.3
COGS
128.1155.5175.5196.9299.3345.5
Gross Profit
115.4138.1152.7174.4150.7201.8
Operating Expenses & Income
Operating Income
(5.322)(2.403)(2.89)7.397(2.201)26.39
Total Operating Expenses
128.2155.1155.5167152.9175.4
R&D Expenses
12.6914.7617.5523.328.9837.89
Selling General & Admin Expenses
37.1640.1537.4145.4956.1896.82
Earnings from Continuing Operations
Interest Expense
(3.618)(6.6)(12.49)(9.223)(10.42)(11.06)
Interest Income
7.38215.7628.516.236.2065.798
Income Tax Expense
(8.985)(14.07)(5.153)(2.28)(1.328)6.514999
Net Income
Net Income
15.68(29.89)(16.84)4.332(5.374)14.87
Supplemental
EBIT
(5.322)(37.36)(9.5)11.28(2.201)26.2
EBITDA
42.5925.2640.964.3854.3790.25
In millions of CAD, except % and values per 1 share